Skip to content
Congress·In Committee·11 months ago

House Bill Would Create White House-Led Biotechnology Office to Boost U.S. Competitiveness

Also known as: National Biotechnology Initiative Act of 2025

Legislative Progress

Filed
Review
House
Senate
President

Impacts

Mixed Impacts(7)
Student
Neutral
Small Business Owner
Neutral
Gig Worker
Neutral
Chronic Illness
Neutral
Farmer Rancher
Neutral
Federal Employee
Neutral
Military Active
Neutral
Positive Impacts(2)
Military Veteran
Helps
Student Loans
Helps

Key Points

  • Creates a government-wide biotechnology effort, led from the White House, to boost national security and U.S. competitiveness.
  • Sets up a new coordination office and an interagency committee so agencies like Agriculture, Defense, Health, and EPA work from one plan.
  • Directs agencies to speed up research, improve biological data systems, and help companies turn biotech inventions into real products.
  • Pushes “regulatory streamlining” so biotech products can move through federal review with clearer steps, timelines, and a one-stop online portal.
  • Authorizes funding through the National Science Foundation to run the coordination office: $22 million (2026), $35 million (2027), and $25 million each year (2028–2030).
TechnologyArtificial IntelligenceNational SecurityTradeEducation

Milestones

2 milestones2 actions
Apr 9, 2025House

Referred to the Committee on Science, Space, and Technology, and in addition to the Committees on Foreign Affairs, Agriculture, Energy and Commerce, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Apr 9, 2025

Introduced in House

What Happens Next

Projected impacts based on AI analysis

Within 180 days after the bill becomes law

Interagency committee is set up to coordinate biotech work across federal agencies

More decisions about biotech funding, regulation, and security will be coordinated across agencies instead of handled in separate silos.

Within 180 days after the bill becomes law

National Biotechnology Coordination Office is created inside the Executive Office of the President

A new central office becomes the main “hub” for biotech strategy, data coordination, workforce planning, and regulatory coordination.

Within 180 days after the bill becomes law

Director of the National Biotechnology Coordination Office is appointed

This person becomes the main federal point person for biotech, helping set priorities and push agencies to align on funding and rules.

Within 540 days after the bill becomes law

Public federal biotech website goes live (with funding dashboard and plain-language info)

Researchers, companies, and the public get a single place to find biotech funding opportunities, learn basics, and ask questions for a coordinated answer.

Within 1 year after the bill becomes law

Plan for regulatory streamlining is published for the public

Companies and researchers may get clearer expectations for what data is needed, how long reviews take, and which agency leads for different biotech products.

Within 1 year after the bill becomes law (and yearly after that, except strategy years)

First annual report on biotech spending and activities is sent to Congress

The public and lawmakers get a clearer picture of where biotech dollars go and what agencies plan to do next year.

Within 2 years after the bill becomes law (then every 5 years)

First national biotechnology strategy is released to the public

You may see clearer national priorities (health, agriculture, energy, security) and proposals for new programs, with a budget outline for urgent gaps.

Within 3 years after the bill becomes law (then repeats every 5 years)

Government Accountability Office begins a review of whether coordination is working

If the program is duplicating work or missing goals, GAO findings can pressure agencies and Congress to make fixes.

20 years after the bill becomes law

Coordination Office winds down and shifts to a smaller “secretariat” role

After two decades, the day-to-day coordination would move more to the interagency group, potentially changing how fast priorities and regulatory fixes move.

Related News

6 articles

Source Information

Document Type

Congressional Bill

Official Title

National Biotechnology Initiative Act of 2025

Bill NumberHR 2756
Congress119th Congress
ChamberHouse of Representatives
Latest ActionReferred to the Committee on Science, Space, and Technology, and in addition to the Committees on Foreign Affairs, Agriculture, Energy and Commerce, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Sponsor

Cosponsors

(14)
D: 8R: 6

Analysis generated by AI. While we strive for accuracy, this should not be considered legal or professional advice. Always verify information with official government sources.